It is not recommended simultaneous use with monoamine oxidase (MAO) inhibitors due to a significant increase in hypotensive effect. A break in treatment between taking MAO inhibitors and metoprolol should be at least 14 days.
Simultaneous iv injection of verapamil may provoke cardiac arrest.
Simultaneous use of nifedipine leads to a significant decrease in blood pressure.
Means for inhalation anesthesia (halogenated hydrocarbons) increase the risk of oppression of myocardial function and development of arterial hypotension; the sum of the cardiodepressive effect is marked - with the means for general anesthesia; Increased severity of heart rate reduction and depression AV conduction - with the use of metoprolol with verapamil, diltiazem, antiarrhythmic agents (amiodarone), reserpine, methyldopa, clonidine, guanfacin, general anesthetic agents and cardiac glycosides.
Beta-adrenomimetics, theophylline, cocaine, estrogens (sodium ion retention), indomethacin and other non-steroidal anti-inflammatory drugs (sodium retention and blockage of prostaglandin synthesis by the kidneys) weaken the hypotensive effect.
Tri- and tetracyclic antidepressants, antipsychotics (antipsychotics), sedatives and hypnotics increase the depression of the central nervous system.
Increased inhibitory effect on the central nervous system - with ethanol; increased risk of violations of peripheral circulation - with ergot alkaloids.
When combined with hypoglycemic agents for oral administration, a decrease in their effect is possible; with insulin - increased risk of hypoglycemia, increased its severity and lengthening, masking some symptoms of hypoglycemia (tachycardia, sweating, increased blood pressure).
When combined with antihypertensive agents, diuretics, nitroglycerin, or blockers of "slow" calcium channels, a sharp decrease in blood pressure can develop, special caution is necessary when combined with prazosin.
If metoprolol and clonidine take simultaneously, then with the cancellation of metoprolol clonidine cancellation after a few days (due to the risk of the syndrome of "withdrawal").
Inductors of microsomal liver enzymes (rifampicin, barbiturates) lead to increased metabolism of metoprolol, a decrease in the concentration of metoprolol in the blood plasma and a decrease in the effect. Inhibitors of microsomal liver enzymes (cimetidine, oral contraceptives, phenothiazines) - increase the concentration of metoprolol in the blood plasma.
Allergens used for immunotherapy or extracts of allergens for skin tests when combined with metoprolol,increase the risk of systemic allergic reactions or anaphylaxis; iodine-containing radiopaque agents for intravenous administration increase the risk of anaphylactic reactions.
Reduces the clearance of xanthines (except diprofilia), especially with the initially elevated clearance of theophylline under the influence of smoking.
Reduces the clearance of lidocaine, increases the concentration of lidocaine in the blood plasma.
Strengthens and prolongs the action of nondepolarizing muscle relaxants; prolongs the anticoagulant effect of coumarin derivatives.
When combined with ethanol, the risk of a marked decrease in blood pressure increases.
Means that reduce catecholamine stocks (for example, reserpine), can enhance the action of beta-blockers, so patients who take such combinations of drugs should be under constant medical supervision for the detection of excessive reduction in blood pressure or bradycardia.